Sumatriptan Dosing in the Elderly
Start with 25 mg orally for elderly patients, with a maximum single dose of 50 mg, and use cautious dose selection starting at the low end of the dosing range. 1
FDA-Approved Dosing Recommendations
The FDA label explicitly states that dose selection for elderly patients should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function and concomitant disease or other drug therapy in this population. 1
Standard Dosing Options
- Oral tablets: The standard adult doses are 25 mg, 50 mg, or 100 mg, with a maximum of 200 mg per 24-hour period 2
- Subcutaneous: 6 mg, repeated once after 1 hour if needed, not to exceed 12 mg per 24 hours 2
- Intranasal: 5-10 mg (one to two sprays) in one nostril, repeated after 2 hours if needed, maximum 40 mg per day 2
Elderly-Specific Considerations
Cardiovascular Evaluation Required
A cardiovascular evaluation is recommended for geriatric patients who have other cardiovascular risk factors (diabetes, hypertension, smoking, obesity, strong family history of coronary artery disease) prior to receiving sumatriptan. 1 This is critical because sumatriptan is contraindicated in patients with ischemic heart disease, stroke, peripheral vascular disease, or uncontrolled hypertension. 2
Route Selection for Elderly
- Oral route preferred: Start with 25 mg, as clinical trials showed this dose has better tolerability than 100 mg while maintaining efficacy 3
- If subcutaneous needed: Use the standard 6 mg dose, but monitor closely for adverse effects 2
- Intranasal option: 20 mg intranasally (single dose), repeated once after 2 hours if needed, not to exceed 2 doses in 24 hours 2
Common Pitfalls and Safety Concerns
Adverse Events More Common in Elderly
The most frequently reported adverse events include chest discomfort, fatigue, dizziness, paresthesia, nausea, and vomiting. 2 These symptoms may be more problematic in elderly patients with multiple comorbidities. 1
Contraindications to Verify
- Absolute contraindications: Ischemic heart disease, stroke, peripheral vascular disease, uncontrolled hypertension 2
- Severe hepatic impairment: Sumatriptan is contraindicated; for mild to moderate hepatic impairment, maximum single dose should not exceed 50 mg 1
- Drug interactions: Do not use within 24 hours of ergotamine derivatives or other triptans 2
Dosing Algorithm for Elderly Patients
- Initial assessment: Perform cardiovascular evaluation if risk factors present 1
- Starting dose: Begin with 25 mg orally 1
- Repeat dosing: If headache returns, may repeat after 2 hours, maximum 200 mg per 24 hours 2
- Dose adjustment: If 25 mg ineffective after treating 2-3 attacks, may increase to 50 mg (but not 100 mg in elderly) 1, 3
- Alternative routes: Consider intranasal 20 mg or subcutaneous 6 mg if oral route inadequate, but monitor closely 2
Monitoring Requirements
- Chest symptoms: Monitor for chest tightness, pressure, or discomfort, which occur in 3-5% of patients 4
- Blood pressure: Check for orthostatic hypotension and ensure hypertension is controlled 2
- Recurrence: Approximately 40% of patients experience headache recurrence within 24 hours; a second dose may be given but should not exceed daily maximum 4, 5